Adverum Biotechnologies price target lowered to $12 from $15 at RBC Capital
PremiumThe FlyAdverum Biotechnologies price target lowered to $12 from $15 at RBC Capital
1M ago
Adverum Biotechnologies reports Q2 EPS (89c), consensus ($1.47)
Premium
The Fly
Adverum Biotechnologies reports Q2 EPS (89c), consensus ($1.47)
1M ago
Adverum Biotechnologies Reports Second Quarter 2024 Financial Results and Provides Program and Corporate Highlights
Premium
Press Releases
Adverum Biotechnologies Reports Second Quarter 2024 Financial Results and Provides Program and Corporate Highlights
1M ago
Adverum Biotechnologies’ Promising AMD Treatment Advances
PremiumCompany AnnouncementsAdverum Biotechnologies’ Promising AMD Treatment Advances
2M ago
4D Molecular price target lowered to $40 from $63 at BMO Capital
Premium
The Fly
4D Molecular price target lowered to $40 from $63 at BMO Capital
2M ago
Adverum Biotechnologies to host conference call
Premium
The Fly
Adverum Biotechnologies to host conference call
2M ago
Adverum Biotechnologies Announces Leadership Team Changes
PremiumCompany AnnouncementsAdverum Biotechnologies Announces Leadership Team Changes
3M ago
Adverum Biotechnologies Announces Appointments of Dr. Rabia Gurses Ozden as Chief Medical Officer and Dr. Szilárd Kiss as a Member of the Board of Directors
Premium
Press Releases
Adverum Biotechnologies Announces Appointments of Dr. Rabia Gurses Ozden as Chief Medical Officer and Dr. Szilárd Kiss as a Member of the Board of Directors
3M ago
Adverum Biotechnologies appoints Ozden as CMO, Kiss to board of directors
Premium
The Fly
Adverum Biotechnologies appoints Ozden as CMO, Kiss to board of directors
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100